CarthaGenetics® is participating to the 8th World Congress on Rare Diseases and Orphan Drugs, November 21-22, 2018, at Holiday Inn Hotel, Paris-Marne La Vallee, France. If you would like to set up a meeting with us, do not hesitate to contact our CEO Philippe...
CarthaGenetics® Is participating to the 24th annual international partnering conference, BioEurope 2018 from November 5th to 7th, 2018 at the Bella Center Copenhagen, Denmark. If you would like to set up a meeting with us, please contact our CEO Philippe Carteron de Balmont at (phcarteron@carthagenetics.com)...
It is the first time a pharmaceutical company conducts an interactive value demonstration tool for presenting the value of products to physicians in Turkey. We hope to see more creative and interactive examples in near future. For any question concerning this, please contact our Market Access...
CarthaGenetics® Is participating to the 40th Congress of Turkish Respiratory Society, Hotel Rixos, Antalya, Turkey on October 13-15, 2018.If you would like to set up a meeting with us, please contact Mrs Filiz Çavuş at (cavus@carthagenetics.com) or Mr. Mustafa Aydin at (aydin@carthagenetics.com) .we would...
CarthaGenetics® will attend the Cell & Gene Meeting on the Mesa, 3-5 October 2018, in Estancia La Jolla Hotel and Spa, San Diego, CA.If you would like to arrange a meeting with us, do not hesitate to contact our International Business Development Director, Dr...
CarthaGenetics® will attend Swiss Biotech Day, Fall on 27th of September 2018 in Aquatis Conference Center, Biopôle, Lausanne, Switzerland.If you would like to arrange a meeting with us, do not hesitate to contact our CEO Philippe Carteron de Balmont at(phcarteron@carthagenetics.com) . ...
CarthaGenetics® will attend Swiss Biotech Day, Fall on 27th of September CarthaGenetics® is attending the 5th Hematologic Oncology Congress organised by Turkish Hematology Oncology Association between 20-22 September in Acapulco Hotel North Cyprus Turkish Republic.If you would like to arrange a meeting...
CarthaGenetics® Iberica will participate in the benefit gala “Desitjos Enlaire” organized by MPS España for the “15th Anniversary of the MPS Association” on July 13th at 21:00 in Igualada Barcelona. http://www.mpsesp.org.tr/ Do not hesitate to contact us: Philippe Carteron our CEO at (phcarteron@carthagenetics.com) and Samira Benmansour our...
Nobel Ilac is a full-cycle Turkish pharmaceutical company founded in 1964, producing world-class pharmaceuticals for human health. Nobel Ilac provides a global presence of outstanding, reliable and accessible products for human health. CarthaGenetics® is focusing on finding innovative early patients access to medicines for supplying the...
Health Tchnology Assessment (HTA) Report about Hyperthermic Intraperitoneal Chemotherapy (HIPEC) has been published by Ministry of health of Turkey under authorship of Dr. Guvenc Kockaya and contribution of Filiz Cavus Sen. CarthaGenetics® will move forward to support governmental bodies and private institutions for...